May increase blood pressure and/or pulse rate and can present a significant risk for patients with a history certain cardiovascular conditions or stroke.
L’Agenzia Italiana del Farmaco rende disponibile importanti informazioni sull'utilizzo del lotto D01U27121R di KEYVENB e speciali avvertenze e istruzioni per l’uso.
L’Agenzia Italiana del Farmaco rende disponibile importanti informazioni sull'’utilizzo del lotto D01T27121R di KEYVENB e speciali avvertenze e istruzioni per l’uso.
May increase blood pressure and/or pulse rate and can present a significant risk for patients with a history certain cardiovascular conditions or stroke.
May substantially increase blood pressure and/or pulse rate or present a significant risk for patients with a history of certain cardiovascular conditions or stroke.
May illicit inflammatory responses, both chronic and acute, and may be life threatening.
FDA advises consumers to stop using products labeled OxyElite Pro while the investigation continues.
In extreme cases, may cause a failure of the automatic ventilation function of the device.
80.211.154.110
